Watermark
  Back to Search Results

BGB-3111-305

Completed

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-305

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03734016

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2018

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20190098

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan